Giuliani, Nicola

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Giuliani, N., Bataille, R., Mancini, C., Lazzaretti, M., & Barillé, S. (2001) · Blood

Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments

Cited by 415

Multiple myeloma bone disease: pathophysiology of osteoblast inhibition

Giuliani, N., Rizzoli, V., & Roodman, G. D. (2006) · Blood

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 302

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.

Giuliani, N., Colla, S., Sala, R., Moroni, M., Lazzaretti, M., La Monica, S., Bonomini, S., Hojden, M., Sammarelli, G., Barillè, S., et al. (2002) · Blood

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 270

Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes

Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., & Pedrazzoni, M. (2001) · Experimental Gerontology

Cytokine Signaling Pathways and InteractionsMenopause: Health Impacts and Treatments

Cited by 151

Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome

Colla, S., Ong, D. S. T., Ogoti, Y., Marchesini, M., Mistry, N. A., Clise-Dwyer, K., Ang, S. A., Storti, P., Viale, A., Giuliani, N., et al. (2015) · Cancer Cell

Telomeres, Telomerase, and SenescenceAcute Myeloid Leukemia Research

Cited by 105

GPNA inhibits the sodium-independent transport system l for neutral amino acids

Chiu, M., Sabino, C., Taurino, G., Bianchi, M. G., Andreoli, R., Giuliani, N., & Bussolati, O. (2017) · Amino Acids

Amino Acid Enzymes and MetabolismCancer, Hypoxia, and Metabolism

Cited by 77

The osteoblastic niche in the context of multiple myeloma

Toscani, D., Bolzoni, M., Accardi, F., Aversa, F., & Giuliani, N. (2015) · Annals of the New York Academy of Sciences

Multiple Myeloma Research and TreatmentsHematopoietic Stem Cell Transplantation

Cited by 52

Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability

Chiu, M., Toscani, D., Marchica, V., Taurino, G., Costa, F., Bianchi, M. G., Andreoli, R., Franceschi, V., Storti, P., Burroughs-Garcia, J., et al. (2020) · Cancers

Multiple Myeloma Research and TreatmentsAmino Acid Enzymes and Metabolism

Cited by 42

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

Bruzzese, A., Derudas, D., Galli, M., Martino, E. A., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Farina, G., et al. (2022) · Hematological Oncology

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 17

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease

Lungu, O., Toscani, D., Burroughs-Garcia, J., & Giuliani, N. (2023) · International Journal of Molecular Sciences

Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments

Cited by 10

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease

Raimondi, V., Toscani, D., Marchica, V., Burroughs-Garcia, J., Storti, P., & Giuliani, N. (2022) · Frontiers in Oncology

Multiple Myeloma Research and TreatmentsCancer, Hypoxia, and Metabolism

Cited by 10

P-092: Impaired glutamine/glutamate metabolic axis into myeloma microenvironment affects osteoclast formation.

Toscani, D., Chiu, M., Raimondi, V., Iannozzi, N. T., Lungu, O., Garcia, J. B., Notarfranchi, L., Palma, B. A. D., Taurino, G., Bussolati, O., et al. (2022) · Clinical Lymphoma Myeloma and Leukemia

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 2